Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.

Mosakhani N, Missiry ME, Vakkila E, Knuutila S, Vakkila J.

J Pediatr Hematol Oncol. 2017 Nov;39(8):585-588. doi: 10.1097/MPH.0000000000000921.

PMID:
29068867
2.

Narcolepsy patients' blood-based miRNA expression profiling: miRNA expression differences with Pandemrix vaccination.

Mosakhani N, Sarhadi V, Panula P, Partinen M, Knuutila S.

Acta Neurol Scand. 2017 Nov;136(5):462-469. doi: 10.1111/ane.12749. Epub 2017 Mar 1.

PMID:
28251619
3.

MicroRNA and protein profiles in invasive versus non-invasive oral tongue squamous cell carcinoma cells in vitro.

Korvala J, Jee K, Porkola E, Almangush A, Mosakhani N, Bitu C, Cervigne NK, Zandonadi FS, Meirelles GV, Leme AFP, Coletta RD, Leivo I, Salo T.

Exp Cell Res. 2017 Jan 1;350(1):9-18. doi: 10.1016/j.yexcr.2016.10.015. Epub 2016 Oct 20.

PMID:
27773646
4.

Simultaneous Underexpression of let-7a-5p and let-7f-5p microRNAs in Plasma and Stool Samples from Early Stage Colorectal Carcinoma.

Ghanbari R, Mosakhani N, Sarhadi VK, Armengol G, Nouraee N, Mohammadkhani A, Khorrami S, Arefian E, Paryan M, Malekzadeh R, Knuutila S.

Biomark Cancer. 2016 Jan 12;7(Suppl 1):39-48. doi: 10.4137/BIC.S25252. eCollection 2015.

5.

Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma.

Ghanbari R, Mosakhani N, Asadi J, Nouraee N, Mowla SJ, Yazdani Y, Mohamadkhani A, Poustchi H, Knuutila S, Malekzadeh R.

Iran J Cancer Prev. 2015 May;8(3):e2329. doi: 10.17795/ijcp2329. Epub 2015 May 22.

6.

Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.

Ghanbari R, Mosakhani N, Asadi J, Nouraee N, Mowla SJ, Poustchi H, Malekzadeh R, Knuutila S.

Cancer Biomark. 2015;15(2):189-95. doi: 10.3233/CBM-140453.

PMID:
25519020
7.

miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma.

Veija T, Sahi H, Koljonen V, Bohling T, Knuutila S, Mosakhani N.

Virchows Arch. 2015 Mar;466(3):289-95. doi: 10.1007/s00428-014-1700-9. Epub 2014 Dec 10.

PMID:
25491743
8.

Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.

Manceau G, Imbeaud S, Thiébaut R, Liébaert F, Fontaine K, Rousseau F, Génin B, Le Corre D, Didelot A, Vincent M, Bachet JB, Chibaudel B, Bouché O, Landi B, Bibeau F, Leroy K, Penault-Llorca F, Van Laethem JL, Demetter P, Tejpar S, Rossi S, Mosakhani N, Osterlund P, Ristamäki R, Sarhadi V, Knuutila S, Boige V, André T, Laurent-Puig P.

Clin Cancer Res. 2014 Jun 15;20(12):3338-47. doi: 10.1158/1078-0432.CCR-13-2750. Epub 2014 Apr 25.

9.

Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis.

Guled M, Pazzaglia L, Borze I, Mosakhani N, Novello C, Benassi MS, Knuutila S.

Genes Chromosomes Cancer. 2014 Aug;53(8):693-702. doi: 10.1002/gcc.22179. Epub 2014 Apr 26.

PMID:
24771630
10.

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia.

Mosakhani N, Mustjoki S, Knuutila S.

Mol Cytogenet. 2013 Jul 16;6(1):27. doi: 10.1186/1755-8166-6-27.

11.

MicroRNA profiling in chemoresistant and chemosensitive acute myeloid leukemia.

Mosakhani N, Räty R, Tyybäkinoja A, Karjalainen-Lindsberg ML, Elonen E, Knuutila S.

Cytogenet Genome Res. 2013;141(4):272-6. doi: 10.1159/000351219. Epub 2013 May 16.

PMID:
23689423
12.

MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone.

Mosakhani N, Pazzaglia L, Benassi MS, Borze I, Quattrini I, Picci P, Knuutila S.

Histol Histopathol. 2013 May;28(5):671-8. doi: 10.14670/HH-28.671. Epub 2012 Nov 21.

PMID:
23172052
13.

MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF.

Mosakhani N, Lahti L, Borze I, Karjalainen-Lindsberg ML, Sundström J, Ristamäki R, Osterlund P, Knuutila S, Sarhadi VK.

Cancer Genet. 2012 Nov;205(11):545-51. doi: 10.1016/j.cancergen.2012.08.003. Epub 2012 Oct 23.

PMID:
23098991
14.

MicroRNA profiling in pediatric acute lymphoblastic leukemia: novel prognostic tools.

Mosakhani N, Sarhadi VK, Usvasalo A, Karjalainen-Lindsberg ML, Lahti L, Tuononen K, Saarinen-Pihkala UM, Knuutila S.

Leuk Lymphoma. 2012 Dec;53(12):2517-20. doi: 10.3109/10428194.2012.685731. Epub 2012 May 22. No abstract available.

PMID:
22506670
15.

An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma.

Mosakhani N, Guled M, Leen G, Calabuig-Fariñas S, Niini T, Machado I, Savola S, Scotlandi K, López-Guerrero JA, Llombart-Bosch A, Knuutila S.

J Exp Clin Cancer Res. 2012 Mar 20;31:24. doi: 10.1186/1756-9966-31-24.

16.

MicroRNA profiling differentiates colorectal cancer according to KRAS status.

Mosakhani N, Sarhadi VK, Borze I, Karjalainen-Lindsberg ML, Sundström J, Ristamäki R, Osterlund P, Knuutila S.

Genes Chromosomes Cancer. 2012 Jan;51(1):1-9. doi: 10.1002/gcc.20925. Epub 2011 Sep 15.

PMID:
21922590
17.

Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway.

Mosakhani N, Guled M, Lahti L, Borze I, Forsman M, Pääkkönen V, Ryhänen J, Knuutila S.

Mod Pathol. 2010 Nov;23(11):1544-52. doi: 10.1038/modpathol.2010.146. Epub 2010 Jul 30.

Supplemental Content

Loading ...
Support Center